Meet your MIDD Dream Team at ACoP11

Accelerating Medicines to Patients in Partnership with You


At Certara, we help our partners think differently about crucial decisions and reach better outcomes, smarter and faster. We support confident decision-making throughout all phases of drug development, resulting in faster cycle times, lower costs, and better outcomes for patients.

How are we different?

  • 定量的手法の活用:Using modeling and simulation across the entire drug development life cycle, we help to de-risk your program, increase confidence in critical decisions, and help you reach your goals, smarter and faster.
  • 人材:We have the most experienced (and largest) team of experts with clinical pharmacologists, pharmacometricians, and regulatory scientists and writers, that are dedicated to achieve your success.
  • 優れた実績:悪性腫瘍、希少疾患、感染症、神経変性疾患などのパートナーシップに関する成功事例を蓄積しています。

We are excited to see you virtually at ACoP11.  From Certara, we are proud to have 18 speakers who will be participating and many more who will be at the conference to discuss the latest topics on pharmacometrics and model-informed drug development.  Please add them to your calendar and join us for these sessions:  https://www.certara.com/conference/acop11/

Additionally, we are offering limited spots to meet with our leading pharmacometricians to ask questions on how to most effectively implement model-informed drug development approaches in your program.


臨床的価値と経済的価値の評価

詳細は下記までお問い合わせください

A team of experts may be involved in these sessions as subject matter experts depending on the topic.

Rik de Greef, MsC
SVP and Global Lead,
Quantitative Science Services

rik.degreef@Certara.com

  • Joined Certara in 2014 and trained as a PK/PD scientist at Leiden University and based in the Netherlands
  • Previously, was at Organon, Schering-Plough, and Merck/MSD
  • Key interests in integration of model-based components with overall clinical pharmacology and clinical development

Mark Lovern, PHD
SVP and US Head
of Quantitative Science

mark.lovern@Certara.com

  • Joined Certara in 2014; awarded PhD in biomathematics from North Carolina State University
  • Previously was at GSK, UCB, and Quintiles
  • Broad PK/PD modelling experience across variety of therapeutic areas; taught 50+ training workshops on modelling tools and technology

トップに戻る
Powered by Translations.com GlobalLink OneLink Software